Abstract: There is disclosed method of killing nematodes comprising the step of applying an effective amount of a nematicidal composition comprising a terpene component and compositions suitable for use in the method. The terpene component is preferably in association with water, either as a solution or a suspension. An excipient may also be included, which is suitably hollow glucan particles which encapsulate the terpene component.

Abstract: Fibers, which can be used for making wipes (e.g., antimicrobial wipes), wherein the fibers include a core comprising an aliphatic polyester; and an epoxidized fatty ester having greater than 4.7 wt-% oxirane oxygen, based on the total weight of the epoxidized fatty ester; wherein the epoxidized fatty ester is disposed on the surface of the fiber core.

Abstract: The present invention is directed to a nitrogen containing surfactant composition comprising at least one nitrogen containing surfactant of structure (h) or structure (i). The nitrogen containing surfactant of structure (h) is as shown below: Structure (h). The nitrogen containing surfactant of structure (i) is as shown below: Structure (i). The present invention is also directed to an agricultural composition comprising at least one agrochemical and at least one nitrogen containing surfactant composition of the present invention.

Abstract: A cosmetic product for hair bleaching or hair dyeing, which comprises a first part containing an alkali agent, a second part containing hydrogen peroxide, and a non-aerosol foamer container for discharging a mixed solution containing the first part and the second part in the form of foam, wherein the cosmetic product for hair bleaching or hair dyeing contains the following component (A) in the second part: (A) saturated aliphatic alcohols containing the following components (A1) and (A2): R1—OH??(A1) R2—OH??(A2) wherein R1 represents a C12-18 linear chain alkyl group, and R2 represents a C19-24 linear chain alkyl group.

Abstract: The present invention relates to process for preparing cosmetic compositions at two stages. The first relates to the preparation of organogels in which liquid oils are structured by a mixture of structuring agents such as monoglycerides and waxes, which also have the addition of other components such as polymers and polyol esters. The second step is the formation of the cold or hot process cosmetic compositions where emulsions are prepared by the addition of water, aqueous solutions and other components, to the organogel. The emulsions prepared have superior sensory, chemical-physical and stability characteristics, to those currently produced by the classic technology of preparation with emulsifiers.

Abstract: The present invention relates to a composition, preferably a cosmetic composition, in particular for coating keratin fibers such as the eyelashes, comprising:—an aqueous phase,—a lamellar phase L? formed by an aqueous phase-structuring surfactant system, said surfactant system comprising a content of surfactant(s) of greater than or equal to 15% by weight relative to the total weight of the composition,—at least one (poly)vinylpyrrolidone hydrophilic polymer present in a content of greater than or equal to 3% by weight of solids relative to the total weight of the composition, the hydrophilic polymer(s) having a weight-average molecular mass Mw ranging from 1500 to 500 000 g/mol. The present invention also relates to a process for coating keratin fibers.

Abstract: The present invention is directed to a depilatory composition which comprises a depilatory active and at least one material which alters the thermal properties of the composition by either having a higher heat of fusion or a lower thermal conductivity than the bulk.

Abstract: A treatment system and method includes use of a chemical facilitator to provide a result-effective event against one or more negative therapeutic effects related to exposing to a light output a skin portion including a condition treatable in whole or in part with light. In one exemplary embodiment for skin treatment including tattoo removal, perfluorodecalin is used to inhibit or resolve whitening, for example to speed a laser therapy session.

Abstract: Wipes for preventing quaternary ammonium (“quat”) depletion suitable for commercial applications (e.g., industrial and consumer disinfectant wipes) are provided. The wipe includes at least one nonwoven layer, at least one pulp layer, and a cationic additive. The at least one nonwoven layer and the at least one pulp layer may be hydroentangled to form a hydroentangled nonwoven fabric having a first surface and a second surface. Additionally, the cationic additive may be disposed on at least one of the first surface or the second surface.

Abstract: A veterinary pharmaceutical composition, including at least one active veterinary pharmaceutical substance which is selected among gonadorelin and gonadorelin analogs as well as salts of gonadorelin and of the gonadorelin analogs, is provided. The composition includes a liposome-free matrix which delays the release of the active veterinary pharmaceutical substance from the composition, which matrix includes a basic material which is selected from the group consisting of natural and synthetic triglycerides, vegetable oils, diacylpropanediols, diacylbutanediols and mixtures of these substances, the veterinary pharmaceutical composition including no biodegradable polymer.

Abstract: Contact lenses are described that include particles of polymer fiber mat incorporated into a polymer lens wherein the polymer fiber mat is formed by electrospinning a prepolymer solution. Methods for making the contact lenses with improved oxygen permeability are also described. Methods for making the contact lens with optional therapeutic drug delivery and refractive correction are also described.

Abstract: Substrates having formulations disposed thereon, wherein the formulations have improved transfer rates from the substrate to skin, are disclosed herein. More particularly, the formulations can be applied to nonwoven, particularly elastomeric substrates, as well as tissue paper, and can be easily and efficiently transferred from the substrate to the skin of a user upon intimate contact thereto. Laminated articles using one or more of the substrates having the formulations disposed thereon are further disclosed.

Abstract: The present invention relates to a stable fixed dose aqueous pharmaceutical composition (e.g., contained in a container) for nasal administration to a human, comprising mometasone or its salt, olopatadine or its salt. The composition may further include a hydrocolloid. The invention also relates to a process for preparing the pharmaceutical composition, and the use of the pharmaceutical composition in the treatment of rhinitis in a subject.

Abstract: The present invention relates to compositions for controlling plant pests, which contain the compound of the formula (I) in a mixture with fungicidally active compounds, except for cyclopropylcarboxamide derivatives and azolylmethylcycloalkanes.

Abstract: The present invention relates to a composition comprising, in a cosmetically acceptable medium: a) composite particles with a mean size of greater than 0.1 ?m, containing a matrix comprising i) at least one organic material and/or at least one mineral material and ii) at least titanium dioxide; and b) hydrophobic silica aerogel particles. The invention also relates to a cosmetic process for caring for and/or making up human keratin materials, especially bodily or facial skin or the hair, comprising at least the application, to the surface of the keratin material, of a composition as defined previously. The invention also relates to a non-therapeutic cosmetic process for limiting the darkening of the skin and/or improving the color and/or uniformity of the complexion, comprising the application, to the surface of the keratin material, of a composition as defined previously.

Abstract: Provided herein are screening methods for identifying arthropod repellent compounds based on modulation of ionotropic receptors, including an Ir40a receptor, an Ir93a receptor and an Ir25a receptor. Further provided are screening systems related to these methods. Such systems may include a sample that has one or more of the ionotropic receptors; and one or more compounds that each is a repellent for at least one arthropod species, wherein the one or more compound each modulates the activity of such ionotropic receptor(s). Further provided are one or more compounds identified using the screening methods described herein, and compositions containing such compounds.

Abstract: The use of glutathione to treat or prophylax viral, bacterial, chemical, and nuclear agents, or to treat or prophylax radiation injury to humans due to release of radioactive elements. The preferred formulation is an oral dosage form, with reduced glutathione stabilized by ascorbic acid, packaged to under controlled humidity and temperature conditions to ensure creation of charge transfer complexes that ensure consistent packaging, insignificant oxidation during packaging and subsequent normal storage, and high oral bioavailability for humans.

Abstract: A skin cleansing composition is provided. The skin cleansing composition comprises from about 0.1% to about 15%, by weight, of a plurality of biodegradable abrasive particles. The biodegradable abrasive particles comprise a safe and effective amount of polyhydroxy alkanoate (PHA) biodegradable polymeric material and comprise a particle size range from 10 ?m to 1500 ?m. The composition also comprises a multimodal particle size distribution of the biodegradable abrasive particles. The composition further comprises a dermatologically acceptable carrier.

Abstract: The present invention relates to a tablet composition comprising a therapeutically effective dose of cinacalcet hydrochloride having a particle size distribution D90 equal to or less than 30 ?m in an amount of from 40% to 60% by weight based on the total weight of the composition, and one or more pharmaceutically acceptable excipients.

Abstract: Provided herein are screening methods for identifying compounds for use as an arthropod repellent based on the masking or inhibition of the detection of the skin odor by a cpA neuron. Provided herein are also screening methods for identifying compounds for use as an arthropod attractant based on activation of the cpA neuron. Further provided are one or more compounds identified using the screening methods described herein, and compositions containing such compounds.